Skip to main content
. 2016 Nov 6;56(2):287–293. doi: 10.1093/rheumatology/kew386

Table 1.

Clinical and laboratory findings

Patient Age of onset Initial presentation Initial diagnosis Disease course Other involvement CK (IU/l) (first visit)
P1 10 m Motor delay CMD Chronic Nil 352–918
P2 3 y Difficulty in climbing stairs, muscle pain IM Chronic Nil 6175
P3 5 y High CK with motor clumsiness IM Subacute Nil 5453
P4 6 y Asymptomatic high CK MD Chronic Nil 6391
P5 7 y Slow runner IM Chronic Nil 5460
P6 10 y Fatigue, skin rash IM Subacute Fatigue, skin rash 10 891
P7 11 y Fatigue, skin rash DM Subacute Fatigue, skin rash 7508
P8 13 y Difficulty in pedalling and climbing stairs MD Chronic Nil 7183
P9 9 y Difficulty in climbing stairs MD Subacute Nil 9570

CK: creatine kinase; CMD: congenital muscular dystrophy; F: female; IM: inflammatory myopathy; M: male; MD: muscular dystrophy; m: months; y: years.